Creative Medical Technology Holdings Inc (CELZ)
4.92
+0.10
(+2.07%)
USD |
NASDAQ |
Apr 24, 10:13
Creative Medical Technology Holdings Cash from Financing (TTM): -0.271M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.271M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 15.47M |
| December 31, 2022 | 15.47M |
| September 30, 2022 | 24.78M |
| June 30, 2022 | 27.59M |
| March 31, 2022 | 12.22M |
| December 31, 2021 | 12.84M |
| September 30, 2021 | 3.787M |
| June 30, 2021 | 1.152M |
| March 31, 2021 | 1.168M |
| December 31, 2020 | 0.6939M |
| September 30, 2020 | 0.6244M |
| June 30, 2020 | 0.7611M |
| March 31, 2020 | 0.7542M |
| December 31, 2019 | 0.9977M |
| September 30, 2019 | 1.242M |
| June 30, 2019 | 1.349M |
| March 31, 2019 | 1.478M |
| December 31, 2018 | 1.343M |
| September 30, 2018 | 1.031M |
| June 30, 2018 | 0.7022M |
| March 31, 2018 | 0.835M |
| December 31, 2017 | 0.6815M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.9401M |
| June 30, 2017 | 0.9881M |
| March 31, 2017 | 0.7263M |
| December 31, 2016 | 0.677M |
| September 30, 2016 | 0.3046M |
| June 30, 2016 | 0.1685M |
| March 31, 2016 | 0.0596M |
| December 31, 2015 | 0.0139M |
| September 30, 2015 | 0.0175M |
| June 30, 2015 | 0.0177M |
| March 31, 2015 | 0.0179M |
| December 31, 2014 | 0.0179M |
| September 30, 2014 | 0.0172M |
| June 30, 2014 | 0.0182M |
| March 31, 2014 | 0.0187M |
| December 31, 2013 | 0.0225M |
| September 30, 2013 | 0.0215M |
| June 30, 2013 | 0.022M |
| March 31, 2013 | 0.0188M |
| December 31, 2012 | 0.0165M |
| September 30, 2012 | 0.0132M |
| June 30, 2012 | 0.015M |
| March 31, 2012 | 0.0175M |
| December 31, 2011 | 0.0147M |
| September 30, 2011 | 0.0177M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.271M
Minimum
Dec 2023
27.59M
Maximum
Jun 2022
6.349M
Average
1.168M
Median
Mar 2021
Cash from Financing (TTM) Benchmarks
| Avid Bioservices Inc | 9.72M |
| Viking Therapeutics Inc | 271.38M |
| Avinger Inc | 5.112M |
| Aptevo Therapeutics Inc | 5.998M |
| Absci Corp | -4.483M |